Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 7 studies | 25% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1561.83 | 2637 / 2642 | 96% | 5.28 | 675 / 705 |
bladder | 100% | 778.71 | 21 / 21 | 90% | 3.24 | 456 / 504 |
uterus | 100% | 872.99 | 170 / 170 | 88% | 2.78 | 406 / 459 |
thymus | 100% | 1413.64 | 653 / 653 | 78% | 2.33 | 469 / 605 |
prostate | 100% | 1454.58 | 245 / 245 | 77% | 1.97 | 387 / 502 |
intestine | 100% | 1011.51 | 963 / 966 | 77% | 2.59 | 405 / 527 |
esophagus | 99% | 733.08 | 1437 / 1445 | 73% | 1.66 | 134 / 183 |
adrenal gland | 96% | 566.22 | 248 / 258 | 75% | 1.91 | 173 / 230 |
skin | 99% | 701.89 | 1787 / 1809 | 71% | 1.87 | 336 / 472 |
breast | 99% | 650.98 | 455 / 459 | 68% | 1.90 | 765 / 1118 |
ovary | 100% | 1084.78 | 180 / 180 | 64% | 1.63 | 275 / 430 |
stomach | 99% | 759.49 | 356 / 359 | 65% | 2.27 | 185 / 286 |
lung | 99% | 880.92 | 573 / 578 | 63% | 1.71 | 723 / 1155 |
pancreas | 72% | 287.20 | 236 / 328 | 87% | 2.34 | 154 / 178 |
kidney | 100% | 3272.48 | 89 / 89 | 58% | 1.51 | 525 / 901 |
liver | 100% | 8050.89 | 226 / 226 | 54% | 1.32 | 220 / 406 |
spleen | 100% | 2988.75 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.14 | 1 / 1 |
peripheral blood | 100% | 2565.76 | 925 / 929 | 0% | 0 | 0 / 0 |
adipose | 98% | 672.53 | 1180 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 96% | 547.06 | 1282 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 2.27 | 26 / 29 |
heart | 69% | 273.68 | 591 / 861 | 0% | 0 | 0 / 0 |
muscle | 66% | 236.85 | 528 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 60% | 1.07 | 27 / 45 |
eye | 0% | 0 | 0 / 0 | 33% | 0.49 | 26 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002250 | Biological process | adaptive immune response |
GO_0051279 | Biological process | regulation of release of sequestered calcium ion into cytosol |
GO_0050853 | Biological process | B cell receptor signaling pathway |
GO_0051896 | Biological process | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_1901222 | Biological process | regulation of non-canonical NF-kappaB signal transduction |
GO_0043122 | Biological process | regulation of canonical NF-kappaB signal transduction |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005615 | Cellular component | extracellular space |
GO_0019815 | Cellular component | B cell receptor complex |
GO_0019901 | Molecular function | protein kinase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LIME1 |
Protein name | Lck interacting transmembrane adaptor 1 Lck-interacting transmembrane adapter 1 (Lck-interacting membrane protein) (Lck-interacting molecule) |
Synonyms | LP8067 LIME |
Description | FUNCTION: Involved in BCR (B-cell antigen receptor)-mediated signaling in B-cells and TCR (T-cell antigen receptor)-mediated T-cell signaling in T-cells. In absence of TCR signaling, may be involved in CD4-mediated inhibition of T-cell activation. Couples activation of these receptors and their associated kinases with distal intracellular events such as calcium mobilization or MAPK activation through the recruitment of PLCG2, GRB2, GRAP2, and other signaling molecules. . |
Accessions | A0A087WT39 ENST00000309546.8 [Q9H400-1] ENST00000476183.2 A0A087WZP9 V9GYI1 A0A087WUJ1 Q9H400 ENST00000487026.5 ENST00000493265.2 X6RKG5 ENST00000444951.5 ENST00000480139.5 |